Cinacalcet suppresses calcification of the aorta and heart in uremic rats (Q46350266)

21 December 2017

title

Cinacalcet suppresses calcification of the aorta and heart in uremic rats (English)

1 reference

21 December 2017

author name string

Takehisa Kawata

1

1 reference

21 December 2017

Nobuo Nagano

2

1 reference

21 December 2017

Masaki Obi

3

1 reference

21 December 2017

Sonoe Miyata

4

1 reference

21 December 2017

Chika Koyama

5

1 reference

21 December 2017

Nami Kobayashi

6

1 reference

21 December 2017

Sachiko Wakita

7

1 reference

21 December 2017

Michihito Wada

8

1 reference

21 December 2017

language of work or name

English

0 references

publication date

27 August 2008

1 reference

21 December 2017

published in

Kidney International

1 reference

21 December 2017

volume

74

1 reference

21 December 2017

page(s)

1270-1277

1 reference

21 December 2017

issue

10

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.407

exact match

0 references

cites work

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Vascular calcifications in uremia: old concepts and new insights

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Vascular calcification in uremic conditions: new insights into pathogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Management of Secondary Hyperparathyroidism: The Importance and the Challenge of Controlling Parathyroid Hormone Levels without Elevating Calcium, Phosphorus, and Calcium-Phosphorus Product

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Vascular calcification: contribution of parathyroid hormone in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Clinical experience with cinacalcet HCl.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Extracellular calcium-sensing receptor is functionally expressed in human artery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Vitamin D receptor null mutant mice fed high levels of calcium are fertile

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.407

7 January 2021

Identifiers

DOI

10.1038/KI.2008.407

1 reference

21 December 2017

Dimensions Publication ID

0 references

1 reference

21 December 2017